Nouscom Srl
Clinical trials sponsored by Nouscom Srl, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental vaccine aims to boost immune attack on Hard-to-Treat cancers Results expected Oct 2026 (estimated)